Latest / Pharmacy Podcast Network / Opioidology Part 1: Our Opioid Story | Pain Pod
Transcript
- 0:05Speaker 1: You are listening to the global network of podcasters dedicated
- 0:09Speaker 1: to the pharmacy profession. Welcome to the Pharmacy podcast Network.
- 0:20Speaker 1: This is the Pain Pod.
- 0:24Speaker 2: You want to see pain, look at me? Welcome to
- 0:34Speaker 2: the Pain Pod, the podcast for all things pain management,
- 0:39Speaker 2: hosted by the Pain.
- 0:40Speaker 1: Guy, doctor Mark Grow.
- 0:47Speaker 2: We'll be collaborating with numerous pain management experts, talking about
- 0:51Speaker 2: substance usage disorders, the latest treatment modalities, and most important
- 0:57Speaker 2: important focusing on the pain of our patients as leading
- 1:00Speaker 2: providers of pain care. And now here's our host, a
- 1:06Speaker 2: man wanted in all fifty states, a suburban city like
- 1:11Speaker 2: Mountain man without the beard, from the hills of West
- 1:16Speaker 2: Virginia and certified in weapons of mass destruction response.
- 1:22Speaker 1: Yes, Doctor Mark slably welcome everyone to the Pain Pod.
- 1:33Speaker 1: This is a coourse your host, Mark, pain Guy Carofully,
- 1:37Speaker 1: Welcome you back to hopefully back to the Pain Pod.
- 1:42Speaker 1: So we have well we have a little bit of
- 1:43Speaker 1: a treat today. We're we're gonna start an adventure together. Okay. Now,
- 1:48Speaker 1: if you're near to the Paint Pod, welcome aboard. If
- 1:51Speaker 1: you've been here before, well join the career. There's a
- 1:54Speaker 1: lot of us right, So we're gonna start a new
- 1:57Speaker 1: little mini series here on the Pain Pod cud oh Ology. Okay,
- 2:01Speaker 1: We're gonna do a mini series called Opioidology, and part
- 2:05Speaker 1: one is today. Today is going to be our opioid story.
- 2:11Speaker 1: Now most likely or perhaps you've you know, you've heard
- 2:15Speaker 1: a lot, you've seen a lot, and perhaps you've even
- 2:18Speaker 1: experienced a lot within our overall opioid crisis. You know,
- 2:22Speaker 1: some folks will call it opioid epidemic, opioid crisis, overdose crisis,
- 2:29Speaker 1: war on drugs, you name it. But here for this conversation,
- 2:35Speaker 1: we're gonna go over opioidology, Part one, our opioid story.
- 2:41Speaker 1: The overall idea here is to kind of get to
- 2:42Speaker 1: the a little bit of investigative reporting on a part
- 2:46Speaker 1: of yours. Truly really really want to look at the
- 2:49Speaker 1: whole picture, because, like anything else in life, when we
- 2:52Speaker 1: go to the extremes, we have ourselves a good time,
- 2:56Speaker 1: but we miss what's real in the middle. Right, So
- 3:01Speaker 1: we're going to take a little bit of a hot,
- 3:03Speaker 1: tough time machine journey to you know, go back and say,
- 3:05Speaker 1: you know, how do we get in this pickle? Right?
- 3:08Speaker 1: You know, not the one that goes in Christmas trees
- 3:11Speaker 1: that time a year. But how do we get in
- 3:13Speaker 1: this scenario in the first place? And perhaps we could
- 3:17Speaker 1: you know, learn from the past and the present and
- 3:19Speaker 1: how to have some hope for the future, because that's
- 3:22Speaker 1: certainly needed. Right, So we'll go on this journey, well,
- 3:28Speaker 1: you know, and it's the idea is to not be
- 3:31Speaker 1: opinionated or biased here. It's just you know, looking at it,
- 3:34Speaker 1: to take the gloves off right of you know, where
- 3:38Speaker 1: where how did we get here? So first up on
- 3:41Speaker 1: our journey, I'd like to go back. Well, we'll go
- 3:45Speaker 1: back maybe a little bit more than one hundred years
- 3:46Speaker 1: or so. So our United States are US Opium Commissioner.
- 3:51Speaker 1: Yeah that was a position. It's technically back in nineteen eleven.
- 3:54Speaker 1: But yeah, we'll say like a little bit over one
- 3:56Speaker 1: hundred years ago. A guy by the name of Hamilton. Right,
- 4:00Speaker 1: everybody likes dropping quotes, right, Well, here goes one from
- 4:02Speaker 1: mister Hamilton. Right. Of all the nations of the world,
- 4:06Speaker 1: the United States consumes the most habit forming drugs per
- 4:09Speaker 1: capita end quote. Has it changed? Not necessarily. Now we're
- 4:15Speaker 1: going to touch on looking at a global perspective, because folks,
- 4:18Speaker 1: we're not alone but by golly, we lead. Now if
- 4:22Speaker 1: we're going to drop some quotes, I'm going to drop
- 4:24Speaker 1: one of my own here for us. Okay, here's here's
- 4:26Speaker 1: something I you might observe this too, hopefully, right. You
- 4:30Speaker 1: know this constant the idea of substance use compared to
- 4:35Speaker 1: substance use disorder addiction. Right, And you know it's not
- 4:39Speaker 1: this step wise approach or the pyramid where things continue
- 4:42Speaker 1: to escalate and all that. What I'm talking about here
- 4:45Speaker 1: is that, you know, overdose deaths. That's the core of
- 4:48Speaker 1: this opiate crisis that is on headlines everywhere and has
- 4:52Speaker 1: been right headlines, grants and heart beats, there's another title
- 4:57Speaker 1: for you. But you know there's difference between a weekend
- 5:01Speaker 1: warrior or even a Thursday night warrior. And you know
- 5:04Speaker 1: someone actually endeavoring into substance use disorder is a big
- 5:07Speaker 1: difference actually, right, But either of those situations could end
- 5:10Speaker 1: up in overdose deaths, lost heart beats. Right. So you know,
- 5:14Speaker 1: here's my idea, perhaps yours too. Substance use and substance
- 5:18Speaker 1: use disorder are not the same thing. Let's take a
- 5:21Speaker 1: moment to breed that in folks. All right, Now that
- 5:25Speaker 1: you took your moment, you know, speaking of our opiate
- 5:29Speaker 1: it's story. You know, I'd be remiss not to mention
- 5:32Speaker 1: that there's a lot of stories out there. There's a
- 5:34Speaker 1: lot of books, I should say, right, perhaps you've read
- 5:38Speaker 1: a one, two, or a dozen or two of them
- 5:41Speaker 1: that are out there. We have things like and and
- 5:43Speaker 1: by the way, I'm not tied to any books I
- 5:44Speaker 1: know authors, but you know you do too, I'm sure.
- 5:47Speaker 1: But there's Chasing the Scream, you know, on Harri Drunk
- 5:50Speaker 1: Dealer MD, Dreamland from Sam his newer one being The
- 5:54Speaker 1: Least of Us. I've mentioned some of these on some
- 5:57Speaker 1: of the other Paint Pot episodes, but I the list
- 6:00Speaker 1: could go on Dopamine Nation, Unfit for Recovery. We had
- 6:04Speaker 1: Jake here on the Pain Pod. Actually, we had Sam
- 6:06Speaker 1: here on the Pain Pod too. Sam Quinone is from
- 6:08Speaker 1: Dreamland in the Least of Us, FEN and the Incorporated
- 6:11Speaker 1: Killing Season, the United States of Opioids, American Fix Narconomics.
- 6:15Speaker 1: It's got that bright yellow cover. It just kind of
- 6:17Speaker 1: stands out. It's the economist saying, hey, I want you
- 6:20Speaker 1: to listen to us, to their healthcare professionals and policymakers.
- 6:24Speaker 1: High achiever. I remember recommending that one to sweet little Grandma,
- 6:30Speaker 1: to both of our boys, young boys, and recommend it
- 6:35Speaker 1: to anybody really, But you know, it's the point of
- 6:37Speaker 1: view of somebody that endeavors into the jail system. Not
- 6:40Speaker 1: many of us have experience with that, right, Yeah, and
- 6:43Speaker 1: well it's good things to pull from that disclaim it.
- 6:46Speaker 1: There's a lot of potty mouth in that particular work
- 6:50Speaker 1: of literature. We can go on name twenty five others easily, right,
- 6:56Speaker 1: But there's a lot of those stories out there, and
- 7:00Speaker 1: that informs our overall knowledge. Right. It's the same thing.
- 7:04Speaker 1: You know, there's a lot of streaming streamers that are
- 7:07Speaker 1: out there, documentaries, TV shows, movies, you name it. You
- 7:10Speaker 1: know you've watched a couple of them. I'm more guilty
- 7:13Speaker 1: than you, or I've tried to watch them all, but
- 7:15Speaker 1: that's probably impossible. A couple that come to mind, drugs inc.
- 7:21Speaker 1: It's gosh, goes over all different types of the substances.
- 7:25Speaker 1: Hamilton's pharmacal p is very similar to that, but you know,
- 7:27Speaker 1: certainly unique. We got American pain Breaking Bad. I mean
- 7:34Speaker 1: I've learned to ask who hasn't watched Breaking Bad? I
- 7:36Speaker 1: know you're out there, get her done? Already Dope Sick narcos.
- 7:42Speaker 1: Other Netflix ones being Heroin or Recovery Boys, those last
- 7:45Speaker 1: two right from Wild to Wonderful West Virginia. You know
- 7:48Speaker 1: yours truly stomping grounds Recovery Boys usually you see the
- 7:53Speaker 1: picture of that. You know, if there's a movie poster
- 7:55Speaker 1: type thing with Ryan with the baseball cap. What an
- 7:59Speaker 1: amazing individual, right boy, We've endeavored into some things with
- 8:04Speaker 1: him before for spreading the knowledge out there, right, and
- 8:09Speaker 1: you know even bigger screen if folks still go to
- 8:11Speaker 1: the cinemas. Now I get all the fancy chairs. I
- 8:13Speaker 1: love it. But anyways, Scarface back in the day, Yeah,
- 8:17Speaker 1: say hello to my little friend pain guy, No Scarface,
- 8:20Speaker 1: al right? How about Lord? The Rings? Right? Yeah, the Ring,
- 8:24Speaker 1: the Ring, the precious cocaine, Math, Heroin. It's the whole
- 8:28Speaker 1: thing has an undertotal addiction the entire time, all of them. Right,
- 8:32Speaker 1: all right, I'm diving deep. You're here apparently joining me
- 8:35Speaker 1: on this, uh you know, going through books and movies
- 8:38Speaker 1: and all that kind of stuff. But let's hold it
- 8:40Speaker 1: into like back to the timeline here right for a
- 8:42Speaker 1: hot tup time machine. Where did this ruckus of the
- 8:46Speaker 1: opioid crisis all begin right for opioid story here, Well,
- 8:50Speaker 1: law comes into play, right, I'm gonna hesitate these days
- 8:54Speaker 1: with some of these words. But folks are going over law. Okay,
- 8:56Speaker 1: this isn't politics. There's not this side or that side.
- 9:00Speaker 1: It's just it's the laws that were made at the time, right,
- 9:03Speaker 1: all right, So way back in the eighteen hundreds, eighteen
- 9:06Speaker 1: thirty two was actually the first one, the eighteen thirty
- 9:08Speaker 1: two Tariff Act that actually exempted opium from duties, the
- 9:12Speaker 1: import duties. Okay. A decade later opium was headed back
- 9:16Speaker 1: in twenty years after that, morphine was added in specifically.
- 9:20Speaker 1: And then you fast forward about fifty years to the
- 9:22Speaker 1: big one, okay, the nineteen fourteen Harrison Narcotics Tax Act.
- 9:26Speaker 1: You know, for a lot of folks like pharmacists, you know,
- 9:29Speaker 1: US healthcare professionals, the only ones that have a log
- 9:32Speaker 1: exam for licensure. You know, that's on there right in
- 9:35Speaker 1: some way, shape, form or fashion. But that's really the
- 9:39Speaker 1: big one, Okay. Nineteen fourteen, that's when you know, money
- 9:44Speaker 1: and government and substances started overlapping a lot, right, Those
- 9:49Speaker 1: are the federal tax in common and criminal liability. Right,
- 9:54Speaker 1: that's really a big one, you'd have to fast forward
- 9:57Speaker 1: another fifty some years really to the nineteen seventies for
- 10:01Speaker 1: the Controlled Substance Act, the nineteen seventy Controlled Substance Act,
- 10:04Speaker 1: that's where we really started getting our ducks in a row.
- 10:07Speaker 1: Our ducks are still quacking all over the place, folks,
- 10:10Speaker 1: They're not walking a straight line. But that's where we
- 10:13Speaker 1: made our you know, the controlled substance classes one through
- 10:17Speaker 1: five generally speaking, usually basing those off a couple things,
- 10:21Speaker 1: but the two main things being generally accepted medical use
- 10:24Speaker 1: and then potential for abuse. Right, that's that's a big one.
- 10:30Speaker 1: And by the way, internationally, you know, in being the
- 10:35Speaker 1: country that leads the way for a lot of these
- 10:38Speaker 1: substance concerns, we also lead the way in shaping and
- 10:42Speaker 1: informing laws all across the globe. Right, it's a lot
- 10:46Speaker 1: of International Narcotic Control Board information and actions that are
- 10:51Speaker 1: out there very similar to basically what we've done with
- 10:54Speaker 1: our controlled substance classes. But then again all over the
- 10:57Speaker 1: place too, there's countries, there's multiple countries with the penalty
- 11:00Speaker 1: for drug possession. Breathe that one in too, right, good golly. Now,
- 11:08Speaker 1: Also in the nineteen seventy three Right after that we
- 11:10Speaker 1: had the DEA. The Drug Enforcement Agency was established. That
- 11:14Speaker 1: was under a President Nixon executive order. The year prior, actually,
- 11:17Speaker 1: they started the Office for Drug Abuse Law Enforcement as well.
- 11:22Speaker 1: So a lot of action around the time of President
- 11:25Speaker 1: Nixon's administration. Again already prempted not going political here, folks,
- 11:29Speaker 1: I felt the need to say that after this next
- 11:31Speaker 1: tidbit of info. All right, for the first time the
- 11:34Speaker 1: history of mankind, paying guy on the pain pod is
- 11:36Speaker 1: going to read something. Okay, these are not my words.
- 11:41Speaker 1: These are quotes from John Erlickman, that was the top
- 11:45Speaker 1: advisor to the president at the time. Okay, in the
- 11:48Speaker 1: same campaign. So here's the quote. Okay, start quote. The
- 11:52Speaker 1: Nixon campaign in nineteen sixty eight and the Nixon White
- 11:54Speaker 1: House after that had two enemies, the anti war left
- 11:56Speaker 1: and black people. You understand what I'm saying that John's words.
- 12:01Speaker 1: By the way, we knew we couldn't make it illegal
- 12:03Speaker 1: to be either against the war or black, but by
- 12:05Speaker 1: getting the public to associate the hippies with marijuana and
- 12:08Speaker 1: blacks with heroin, and then criminalizing both heavily, we could
- 12:11Speaker 1: disrupt those communities. We could arrest their leaders, raid their homes,
- 12:14Speaker 1: break up their meetings and vilify them night after night
- 12:17Speaker 1: on the evening news. Did we know we were lying
- 12:19Speaker 1: about the drugs? Of course we did. End quote, folks,
- 12:23Speaker 1: if you ever hit rewind good Gully, I don't recommend it.
- 12:26Speaker 1: Actually think about that. That's a presidential top advisor on
- 12:29Speaker 1: record saying what I just read. Okay, in the undertow
- 12:35Speaker 1: of a lot of this, there's a lot going on.
- 12:37Speaker 1: It continues today and dare we say, hopefully not in
- 12:41Speaker 1: the future, but most likely right, you know, we're all human, right,
- 12:45Speaker 1: all right, let's jump to like the next decade. In
- 12:48Speaker 1: the eighties, a lot going on. In the eighties there
- 12:50Speaker 1: was actually the Anti Drug Abuse Act. That's where we had,
- 12:54Speaker 1: you know, basically the we started getting more of the
- 12:58Speaker 1: punitive system, the criminality side of things. Right along the
- 13:03Speaker 1: same times, the same decade we had, of course just
- 13:06Speaker 1: say no as the campaign, we had the egg ad.
- 13:08Speaker 1: Who doesn't know the egg ad? Right? If you don't, folks,
- 13:11Speaker 1: google it right. It turns out if well, if you're
- 13:15Speaker 1: a student, pharmacist or a student anybody, you know, you
- 13:17Speaker 1: didn't see it, you gotta google it. Right. There's a
- 13:20Speaker 1: DARE program as well, funky story with that one. So
- 13:23Speaker 1: in Pennsylvania and other states too, if you get the
- 13:27Speaker 1: Drug Abuse Resistance Education the DARE program license plate for
- 13:30Speaker 1: your vehicle, it's black. It looks nice on another black vehicle. Right.
- 13:34Speaker 1: I did that when I was like my first ride,
- 13:37Speaker 1: like literally when first getting licensed to drive. And I
- 13:40Speaker 1: actually had somebody ask me, oh, is is one of
- 13:43Speaker 1: your parents in law enforcement? Like no, I literally just
- 13:47Speaker 1: wanted that to match my car color. But anyways, and
- 13:50Speaker 1: here we are, Oh man, amazing journey. Right, But yeah,
- 13:53Speaker 1: a lot going on in the eighties in that regard.
- 13:56Speaker 1: Then that sets up the nineties of course, where who
- 13:58Speaker 1: we start having the waves of the old boid crisis? Right,
- 14:02Speaker 1: but before we mentioned words like Purdue, you know obviously
- 14:05Speaker 1: the Chicken or the university I want to pull to
- 14:09Speaker 1: know where we get info from. Right, Oh, there's some
- 14:12Speaker 1: bad words out there, like some most would say journal club,
- 14:15Speaker 1: right who Yeah, not a lot of fans out there,
- 14:19Speaker 1: but there are. Right, It's because we just need to
- 14:22Speaker 1: look stuff up and verify it, right, particularly an age
- 14:24Speaker 1: of AI and everything else. Right, But you know, back
- 14:29Speaker 1: in twenty seventeen, the CDC had their usual weekly report
- 14:34Speaker 1: MMWR and that report, it was in March, was utilized
- 14:40Speaker 1: to get headlines that would say, oh, seventy five percent
- 14:42Speaker 1: of hero when the utilizers started with prescription opioids. Okay,
- 14:45Speaker 1: and the report was legit, right, but you got to
- 14:48Speaker 1: dive a little bit deeper. Right. Of course things were
- 14:50Speaker 1: worded different too. But if you'll get some DEA reports
- 14:53Speaker 1: from this, you know, the same time, they'd say, yeah,
- 14:56Speaker 1: but two thirds of them were not from you war
- 14:59Speaker 1: i as license healthcare professionals. It would be from friends, relative,
- 15:03Speaker 1: or dealers for money or just you know, in kind, right,
- 15:08Speaker 1: And then another similar report would say, well, why most
- 15:11Speaker 1: folks would think, oh, to get high utopia right, euphouria
- 15:14Speaker 1: along the way. Nope, like eighty some percent of the
- 15:17Speaker 1: time would be other things like pain, sleep, emotions along
- 15:21Speaker 1: the way. That's often omitted from things like oh, saying
- 15:24Speaker 1: the waves of the opioid crisis. Right, we had wave
- 15:28Speaker 1: one with you know, basically the nineties and early two
- 15:30Speaker 1: thousands with the prescription opioids. Then heroin started taking over
- 15:34Speaker 1: for you know, eh, two thousand and five for about
- 15:37Speaker 1: five six years or so, and then the synthetic opioids
- 15:40Speaker 1: aka fentanyl started taking over and still predominate today, along
- 15:45Speaker 1: with things like stimulants of math and even cocaine making
- 15:47Speaker 1: it come back too. Now the tricky part though, is,
- 15:51Speaker 1: you know, most have seen the slides for like, oh,
- 15:53Speaker 1: the waves of the opioid crisis, right, but then it's
- 15:57Speaker 1: just not enough for this guy. So a little investigative
- 16:01Speaker 1: reporting went into trying to make my own chart, and
- 16:03Speaker 1: I'm going to put it on the pain guy dot
- 16:05Speaker 1: us website. It's my website, of course, feel free to
- 16:08Speaker 1: check it out. By the way, you can actually message
- 16:09Speaker 1: me on there too. It literally comes to my phone.
- 16:12Speaker 1: The little thing will even vibrate, right. It's better than email,
- 16:16Speaker 1: perhaps not better than texting, but still you know. But anyways,
- 16:20Speaker 1: I'll have it on the pain guy dot us website.
- 16:23Speaker 1: I'm gonna have a chart that just goes further, goes
- 16:26Speaker 1: deeper back, okay, further back really to look at, like, hey,
- 16:30Speaker 1: how about the eighties and you know, the seventies and
- 16:33Speaker 1: even before that end. You know the trends not only
- 16:36Speaker 1: for opiate overdoses, but then opioid prescriptions by prescription count
- 16:41Speaker 1: and then also by potency or the lackluster feeble attempt
- 16:46Speaker 1: at potency with more female gram equivalents or mms. Okay,
- 16:49Speaker 1: but you know two sides of the coin for looking
- 16:50Speaker 1: at that and see the trends over all on how
- 16:53Speaker 1: they you know, not mirror, but they are not parallel.
- 16:56Speaker 1: But you know on the same country road along the
- 16:58Speaker 1: way right. Now, here are some key observations from doing that,
- 17:03Speaker 1: looking at you know, the whole picture. First up, there's
- 17:08Speaker 1: always been overdoses, right, and most would say, well, there
- 17:11Speaker 1: always will be, right, you know, us humans ever since
- 17:15Speaker 1: back in the cave days. Right, you figure out, like, hey,
- 17:17Speaker 1: a puddle of water with some certain things in it,
- 17:20Speaker 1: lightning doesn't need to hit it. But let's say it
- 17:21Speaker 1: for the story, all of a sudden, who that gives
- 17:25Speaker 1: a different effect. We have alcohol, we have other things. Oh,
- 17:27Speaker 1: look at that mushroom over there. I'll look at that barry.
- 17:32Speaker 1: We're pulled to things, right. It's our dopaminergic system and
- 17:35Speaker 1: the whole rest of the gang for neural transmitters.
- 17:37Speaker 2: Right.
- 17:37Speaker 1: But there's always been overdoses, you know, in the late
- 17:41Speaker 1: nineties right, already alluded to this, and you're not living
- 17:44Speaker 1: under rock, you know, we started getting the increase and
- 17:47Speaker 1: the opioids prescribed and dispensed that became similar to overdoses,
- 17:54Speaker 1: but again for twenty five years prior, if not more.
- 17:57Speaker 1: There's just no data going back further. And when I
- 18:01Speaker 1: made my little chart in this overall conversation here, I
- 18:03Speaker 1: used about a half a dozen resources that had dozens
- 18:07Speaker 1: of resources in and of themselves. Okay, but again I'll
- 18:10Speaker 1: have that on a paying guy dot us. But it
- 18:13Speaker 1: is stagnif for at least twenty five years prior. Okay, Now,
- 18:16Speaker 1: the increase in opioids dispensed and prescribed could contribute, right,
- 18:22Speaker 1: I mean we have to admit that, particularly as healthcare professionals,
- 18:27Speaker 1: you know. But then again particularly considering the pill mills
- 18:30Speaker 1: of the time, that was the illegal joints, right, and
- 18:33Speaker 1: any other illegal practices, diversion, so on and so forth. Oxy.
- 18:37Speaker 1: I mean by this time I have to say oxy, right,
- 18:39Speaker 1: all the ali oxen free? Right? Well, it definitely wasn't free.
- 18:43Speaker 1: In the opioid story. Oxy obviously came into play in
- 18:47Speaker 1: December of nineteen ninety five, with approval and marketing started
- 18:50Speaker 1: in nineteen ninety six and proliferated. Right. You've seen the
- 18:54Speaker 1: documentaries or you will. Along the same time, you know,
- 18:58Speaker 1: other things were going on too, What about you know,
- 19:00Speaker 1: pain becoming a vital sign. Most people debate that and go,
- 19:05Speaker 1: you know, they dissent. But then also, you know, I
- 19:09Speaker 1: think back to those cave days. If you put your
- 19:11Speaker 1: hand in fire, what tells you to take it out? Pain? Right?
- 19:16Speaker 1: If something's really wrong, like oh, I broke my leg
- 19:18Speaker 1: and the bonus sticking out, I'm about to bleed out,
- 19:21Speaker 1: what tells me that, you know, we need a tourniquet
- 19:23Speaker 1: or something something like that. Wrap it up, right, Pain,
- 19:27Speaker 1: it helps us even though it sucks, right, So perhaps
- 19:33Speaker 1: you know, but then again, if it's a vital sign. Hey,
- 19:35Speaker 1: here's the tricky part. If it's a vital sign, the
- 19:37Speaker 1: goal is in zero, rest, pray rate, heart rate, the
- 19:42Speaker 1: goal is never zero with that, right, and right alongside
- 19:45Speaker 1: the whole pain vital sign thing is the pain scores.
- 19:48Speaker 1: You know, zero to ten, one to ten. How would
- 19:50Speaker 1: you rate your pain? It's like a hotel stay. There's
- 19:52Speaker 1: no membership card though, I yeah, yeah, yeah. There was
- 19:55Speaker 1: a lot going on around the nineties, right, things led
- 19:57Speaker 1: into that too, all right, So you know, prescribing and
- 20:01Speaker 1: dispensing of prescription opioids it clearly drastically increased. But then
- 20:06Speaker 1: it clearly drastically, you know, decreased afterwards, right, we had
- 20:13Speaker 1: all the laws, regulations, the constraints put on, right, and
- 20:18Speaker 1: it decreased, but it didn't go back to homeostasis or
- 20:22Speaker 1: at least the OG the original level. So there was
- 20:27Speaker 1: about one hundred and twenty five thousand opioid scripts. This
- 20:31Speaker 1: is typically a per capita number, but anyways, it and
- 20:34Speaker 1: then it decreased down to you know, the decrease was appreciable,
- 20:40Speaker 1: or is even appreciable, right, but it's not to the
- 20:42Speaker 1: same level. It's still double what it was back in
- 20:45Speaker 1: say the eighties and early nineties, right now that I
- 20:48Speaker 1: say that, and there's a common out of period. Perhaps
- 20:52Speaker 1: pain wasn't recognized as much back then. So would we
- 20:55Speaker 1: want to go back to the original the OG levels.
- 20:58Speaker 1: Maybe not? Maybe So you know, causation and correlation and opinions,
- 21:07Speaker 1: personal facts, that is, there's a lot out there, right,
- 21:09Speaker 1: But again we want to in this opioid story, we
- 21:11Speaker 1: want to avoid the extremes overall, right, So things to
- 21:15Speaker 1: keep in mind there, so you know, and also on
- 21:18Speaker 1: top of that, the majority, the vast majority of recent
- 21:21Speaker 1: overdose deaths we're attributed to elicit opioids. That's illegal stuff, right.
- 21:26Speaker 1: Prescription opioid overdose deaths have plummeted and plateaued, they haven't disappeared.
- 21:32Speaker 1: But again, where are folks getting them from? Is it
- 21:35Speaker 1: actual you know, from prescribing, dispensing, or is it diversion
- 21:37Speaker 1: or is it because the illicit supply chain that has
- 21:40Speaker 1: nothing to do with the healthcare supply chain. That's US
- 21:43Speaker 1: healthcare professionals. It's not the same thing, different supply chain.
- 21:47Speaker 1: They're actually making, you know, the fake versions, right, and
- 21:50Speaker 1: the pills look so similar to the real deal. Right,
- 21:53Speaker 1: So there's that. And you know, back in the nineties,
- 21:57Speaker 1: the early two thousands, maybe even then, things were stemming
- 22:02Speaker 1: from ilegally diverted prescription opioids. Right, it's not there's someone
- 22:07Speaker 1: else added into the prescribed dispense patient cascade, right, all right?
- 22:15Speaker 1: And not last but another idea. You know, despite the
- 22:19Speaker 1: appreciative decreases in opioids prescribed and dispense overdoses, they've continued
- 22:25Speaker 1: to increase. There's been some short lived decreases, two major
- 22:29Speaker 1: ones one was set for twenty twenty four, even most recently,
- 22:33Speaker 1: but you know, the overdose sorce supply chain has shifted
- 22:38Speaker 1: from the healthcare supply chain with some you know, interesting
- 22:42Speaker 1: players and efforts to the illicit supply chain many moons ago, folks.
- 22:47Speaker 1: And that's that's a big change, right, And there's lots
- 22:52Speaker 1: of articles going into this out there, you know, even
- 22:55Speaker 1: in my own wild and wonderful state of West Virginia.
- 22:57Speaker 1: There was one relatively recent one. Now, folks, you got
- 23:01Speaker 1: to watch because you know, there's a lot of facts
- 23:03Speaker 1: that are thrown out there and then opinions thereafter, or
- 23:05Speaker 1: you know, playing with the data or extrapolating it perhaps
- 23:10Speaker 1: better articulation. But anyways, there was one article basically you know,
- 23:17Speaker 1: talking about overdose deaths in West Virginia, okay, And they
- 23:20Speaker 1: showed from back in like say twenty fifteen the drugs,
- 23:23Speaker 1: the substances involved in overdose deaths, and you know, the
- 23:27Speaker 1: top hitters were heroin, alprazlam, oxycodone, fentanyl, days of PAM,
- 23:32Speaker 1: hydro codone. That's the you know, first half dozen or so, right,
- 23:35Speaker 1: But oxycodon and hydrocodone we're up there. And you know,
- 23:38Speaker 1: either like like a high percentage as well too, whereas
- 23:43Speaker 1: you look at recent times they used twenty twenty three.
- 23:47Speaker 1: But there was you know, hydrocodone was down to like
- 23:49Speaker 1: three percent of the overdose death related deaths, oxycodone like
- 23:53Speaker 1: two and a half percent overall, So drastic decreases, right,
- 23:58Speaker 1: And by the way, whenever we look at the you know,
- 24:00Speaker 1: the post mortem reports and all the numbers saying, hey,
- 24:04Speaker 1: what drugs, what substances were involved in overdose deaths, it
- 24:08Speaker 1: doesn't mean that it was that substance that was the culprit.
- 24:11Speaker 1: You know, the opposite chicken or the egg. You know
- 24:15Speaker 1: who's guilty. Well, they're all on board multiple sedatives, right,
- 24:18Speaker 1: if not stimulants as well too, Right, So it's substance
- 24:22Speaker 1: related deaths that's important to keep in mind. And on
- 24:26Speaker 1: that note, by the way, so some of the recent
- 24:29Speaker 1: numbers have said we've been up as high as like
- 24:31Speaker 1: one hundred and eleven one hundred and ten thousand overdose
- 24:34Speaker 1: deaths a year in our country, But now the most
- 24:38Speaker 1: recent numbers are saying we're down to about eighty thousand.
- 24:42Speaker 1: That's certainly a very good decrease, right, Still eighty thousand
- 24:47Speaker 1: lost heart beats. Right now, speaking of the substances, what
- 24:51Speaker 1: about alcohol, that's like one hundred and fifty alcohol related
- 24:56Speaker 1: deaths Again, related alcohol tobacco still leads the land half
- 25:00Speaker 1: a million tobacco related deaths in our country. That's even
- 25:04Speaker 1: after all the settlements, right, same thing record on repeat.
- 25:08Speaker 1: I caution folks, though, when looking at the numbers, you
- 25:11Speaker 1: know when you're seeing like, oh, well, what states are leading,
- 25:14Speaker 1: and you know the population percentage, you know deaths overall.
- 25:20Speaker 1: You know, I'm not a statistician, I'm a pharmacist, Okay,
- 25:23Speaker 1: but raw numbers and percentages there's a difference, and both
- 25:27Speaker 1: are appreciative. We should perhaps always be looking at both.
- 25:32Speaker 1: And the one story I go into for that usually is, hey,
- 25:35Speaker 1: drug dealer hops on a bus in Ohio, takes the
- 25:37Speaker 1: bus to West Virginia and gets out and sells a
- 25:40Speaker 1: bunch of what's said to be heroin, and a whole
- 25:42Speaker 1: bunch of people overdose. This is a real story actually,
- 25:45Speaker 1: and thankfully no one died, but there was in like
- 25:47Speaker 1: four hours, it was a couple dozen overdoses. Okay, very
- 25:50Speaker 1: concerning hunting to West Virginia for specifics, like almost a
- 25:53Speaker 1: decade ago. If that character, they'll get off the dealer.
- 25:57Speaker 1: The illegal dealer got off the bus in Ohio. The
- 26:01Speaker 1: population percentage of the overdoses, particularly if they were overdose deaths,
- 26:07Speaker 1: would be much different than that of West Virginia because
- 26:10Speaker 1: the population is like six times that in Ohio of
- 26:13Speaker 1: West Virginia, Right, So we got to and you know,
- 26:16Speaker 1: when you look at overdose numbers, West Virginia is typically
- 26:19Speaker 1: towards the top Appalachia of course for the overdose rates.
- 26:23Speaker 1: Yet you know, if there's a thousand overdose deaths lost
- 26:26Speaker 1: heart beats in West Virginia, that's comparat to bowl to
- 26:29Speaker 1: something like five or six thousand in something like Ohio
- 26:32Speaker 1: or Pennsylvania with a much higher population. Right, So we
- 26:37Speaker 1: got to keep that in mind overall. And then when
- 26:39Speaker 1: you look at the global perspective, that comes into play too.
- 26:42Speaker 1: You know that quote from mister Hamilton earlier. Yes, we
- 26:46Speaker 1: lead when it looks at overdose deaths by leaps and
- 26:50Speaker 1: bounds of raw numbers, but when you actually crank out
- 26:53Speaker 1: some numbers. I did this once looking at the overdose
- 26:57Speaker 1: population percentage. There is a country out there that comes
- 27:00Speaker 1: close to us, and we're still leading them. But Estonia
- 27:03Speaker 1: relatively tiny little country. They have like a million people.
- 27:06Speaker 1: We have like three hundred and thirty million people. So
- 27:09Speaker 1: if you look at the population percentage, they're actually relative
- 27:14Speaker 1: to other countries close to us in our overdose death rates.
- 27:16Speaker 1: It's amazing to think about. But again, percentage and run numbers,
- 27:20Speaker 1: it's it's the most simple statistics out there. It's borderline,
- 27:23Speaker 1: just math, right. And when you look across the globe internationally,
- 27:27Speaker 1: by the way, it's still tobacco and alcohol leading the way,
- 27:31Speaker 1: not all the drugs. Not the opioid story here today, right,
- 27:35Speaker 1: but we see you know, across the globe our country, Canada, Russia, Asia,
- 27:40Speaker 1: you know, higher populations seem to end up that that's
- 27:44Speaker 1: one of the observations with more overdose rates too. And
- 27:48Speaker 1: when you think about the substances along the way, you know,
- 27:51Speaker 1: I mentioned the waves of the opioid crisis within this
- 27:54Speaker 1: opioid story. You know, these days it's fentanyl and its
- 27:57Speaker 1: analogs lead the way, a couple of things like xyolizine
- 28:00Speaker 1: and all that. But you know, think back, like a
- 28:03Speaker 1: hundred years ago, you were able to buy a heroin
- 28:05Speaker 1: in the random store of the street, and not like
- 28:08Speaker 1: the street today. We had things that were said to
- 28:11Speaker 1: be medicines that would be there was a cough serp
- 28:13Speaker 1: out there that had alcohol cannabis chloroform and morphine. Yeah,
- 28:19Speaker 1: read that one alcohol, cannabis chloroform and morphine. Hope that
- 28:22Speaker 1: helps with your cough. Heroin was just the equivalent, not
- 28:25Speaker 1: the same as OTC, but the equivalent. We also had
- 28:29Speaker 1: asthmaks cigarettes back then too, But these days, you know,
- 28:32Speaker 1: we have we have different opioids that are out there.
- 28:35Speaker 1: You know, there's the prescription opioids or things even sometimes
- 28:39Speaker 1: OTC like your dextermathwar fin for you know, robo tripping
- 28:43Speaker 1: or low paramid. You know, folks have taken four to
- 28:45Speaker 1: six hundred of those. That's why it's hard to open
- 28:48Speaker 1: up the container when you're pooping everywhere. Good golly. Anyways,
- 28:52Speaker 1: other episodes of the pain pot we've gone into that.
- 28:54Speaker 1: But you know, there's other things out there, like crocodile.
- 28:57Speaker 1: There's a morphine stemming from codeine. Uh. There's research chemicals.
- 29:01Speaker 1: There's tneptine like it looks like a tc in structure.
- 29:05Speaker 1: There's kratum cratam fascinating with. You know, the the overall
- 29:10Speaker 1: idea of low dose simulatory higher dose opioid like dual
- 29:13Speaker 1: mechanism there based on dose salvin orm eyebill gain cambo,
- 29:18Speaker 1: you name it. But you know, heroin is still said
- 29:20Speaker 1: to be out there. But then also we get things
- 29:23Speaker 1: in there now like xylazine. It is not an opioid.
- 29:26Speaker 1: Opioid antagonist like no ox on nelmphine. Don't work on
- 29:29Speaker 1: that because it's not a opioid, but it's going to
- 29:32Speaker 1: lead to that. You know, skin concerns is along the way,
- 29:35Speaker 1: just like with crocodile as well. So now when we're
- 29:38Speaker 1: thinking about all those different opioids, right, including the prescription ones,
- 29:41Speaker 1: one of the paramount questions I got one time doing
- 29:45Speaker 1: a presentation somewhere is and you know, folks were like,
- 29:48Speaker 1: oh at the time, like oh, you listed opioids are
- 29:51Speaker 1: coming from like Mexico or China, so on and so forth.
- 29:54Speaker 1: What about like you know, what about the prescription ones
- 29:57Speaker 1: right like where they come from? So it turns off,
- 30:00Speaker 1: did some international Narcotic Board research and Australia, France, and
- 30:04Speaker 1: Spain produce more opium than anyone on the planet because
- 30:09Speaker 1: they're providing that for you know the use of you know, yes,
- 30:14Speaker 1: opiate's the natural things like morphine, codeine and then the
- 30:18Speaker 1: thebane to then make the semisynthetic opioids that we know
- 30:20Speaker 1: for the plethora of prescription opioids out there. Mentioned heroin,
- 30:25Speaker 1: you know, it's there's countries where it's legal across the pond.
- 30:28Speaker 1: One of my favorite package inserts. The United Kingdom just
- 30:31Speaker 1: has very succinct ones. They've got, you know that available.
- 30:35Speaker 1: It's went in the healthcare supply chain, folks. Though it's
- 30:38Speaker 1: not like out in the street and all that heroin
- 30:41Speaker 1: though you know here and other places it's really fanel
- 30:45Speaker 1: these days. There's some niazines that are added. Those are
- 30:49Speaker 1: new agonists, you know, similar to you know, things like
- 30:51Speaker 1: heroin and morphine xylazine I mentioned, that's you know, the
- 30:55Speaker 1: very potent alpha agonist you know along the way as
- 31:00Speaker 1: we mentioned. But you know, for the product that's out there,
- 31:04Speaker 1: particularly for the illicit opioids, what's dominating the front for
- 31:08Speaker 1: opioid overdoses these days? In our current opioid story, you've
- 31:13Speaker 1: heard it before, folks, it's all about the dosage, baby,
- 31:16Speaker 1: you know, paraphrasing and making it my own here from Paracelsus,
- 31:19Speaker 1: the father of toxicology, when he said, solo dosis facet venim.
- 31:23Speaker 1: The dose makes the poison, not the what it is, right,
- 31:27Speaker 1: So it's all about the dosage, but it's also about
- 31:28Speaker 1: the distribution. I feel like me. You've heard or read
- 31:31Speaker 1: lots of headlines and they say, oh, the DEA or
- 31:34Speaker 1: whoever else seized enough fentanyl to kill every American. Yeah,
- 31:40Speaker 1: but you'd have to get it to every American. And
- 31:42Speaker 1: that's what the cartels are really good at, you know,
- 31:45Speaker 1: move over ups, Amazon and the rest of the crew.
- 31:48Speaker 1: Logistics cartel's got it going on. Okay, they're diversified businesses
- 31:53Speaker 1: these days. That's what they do. That's what leads to
- 31:57Speaker 1: you know, you factor in the dose and the distribution.
- 32:00Speaker 1: That's what leads to the reality that all those numbers
- 32:02Speaker 1: I mentioned earlier, and American dies every six minutes from
- 32:06Speaker 1: a drug overdose. That's a lost heartbeat every six minutes.
- 32:09Speaker 1: The other side, the spectrum of baby is more independent,
- 32:12Speaker 1: not addicted to, but dependent to opioids about every half hour. Okay,
- 32:16Speaker 1: so two times in life. When this paying guy has
- 32:19Speaker 1: some tears birth death right now, To kind of get
- 32:25Speaker 1: towards wrapping up our opioid story here, I just want
- 32:27Speaker 1: to mention there's always help out there for everyone. You know,
- 32:30Speaker 1: there's a narcotics anonymous, there's Nora Non for family and friends.
- 32:34Speaker 1: There's local organizations as well too. For US healthcare professionals,
- 32:39Speaker 1: usually the state Board of Pharmacy will be in collaboration
- 32:42Speaker 1: with the Pharmacist Recovery Networks for each given state. You know,
- 32:47Speaker 1: Charlie Bersarite still has the website USAPRN dot org to
- 32:52Speaker 1: get that information along the way there as well too,
- 32:54Speaker 1: the big pictures. Though, it takes everyone to keep the
- 32:57Speaker 1: boat afloat, including patients, including clinicians along the way, all them, state,
- 33:05Speaker 1: federal law enforcement, distributors, manufacturers, insurance companies, academ you for teaching. Everybody.
- 33:11Speaker 1: Takes all of us to keep the boat a floats.
- 33:13Speaker 1: So where can you go from here? Well, one thing
- 33:15Speaker 1: I typically recommend for folks, particularly our pharmacy friends out there,
- 33:18Speaker 1: there's the APHA Institute every June typically own Utah, the
- 33:22Speaker 1: Utah Experience, Amazing experience. Folks get there, Okay, I need
- 33:28Speaker 1: to get back there quite frankly, I'll call myself out,
- 33:31Speaker 1: but check that one out. If you're going to navigate
- 33:34Speaker 1: on over, mosey on over to paygud dot us, feel
- 33:36Speaker 1: free to check out my ted talk mes Unseene pain
- 33:39Speaker 1: addiction and you okay, check that one out and you know,
- 33:44Speaker 1: certainly any of the other resources along the way there.
- 33:47Speaker 1: Like I said, I'll have the chart they talked about
- 33:48Speaker 1: for this overall opioid story. We've gone over the past,
- 33:52Speaker 1: we've gone over the more recent past, the currents. What
- 33:55Speaker 1: lies ahead, folks, is hope. Hey, we have to continue
- 33:59Speaker 1: doing all the great things we're doing as healthcare professionals
- 34:02Speaker 1: and patients alike to really shift things away from so
- 34:07Speaker 1: many lost heartbeats along the way within our opioid story. So, folks,
- 34:14Speaker 1: that's a wrap for opioid Ology, Part one, our opioid story.
- 34:18Speaker 1: I look forward to Part two coming to a device
- 34:22Speaker 1: near you literally anywhere in the very near future. But
- 34:25Speaker 1: I really want to thank you for your time here
- 34:27Speaker 1: today and in joining us on the Pain Pod. So
- 34:30Speaker 1: from me to you, thank you for your time. But
- 34:33Speaker 1: as always, I wish you a great day every day.
- 34:37Speaker 2: If you'd like to join Mark on the Pain Pod,
- 34:40Speaker 2: send us an email to publish you're at Pharmacy podcast
- 34:44Speaker 2: dot com and make sure to share the show and
- 34:47Speaker 2: subscribe on your favorite podcast directory. Thanks for listening.
- 35:00Speaker 1: M